BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2908720)

  • 1. Hemodynamic effects of celiprolol at rest and during exercise; a comparison with enalapril.
    Ghiringhelli S; Cozzi E; Tsialtas D
    Cardiovasc Drugs Ther; 1988 Jul; 2(2):211-8. PubMed ID: 2908720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antihypertensive effects of celiprolol and enalapril.
    Ghiringhelli S; Cozzi E; Tsialtas D
    J Int Med Res; 1988; 16 Suppl 1():73A-79A. PubMed ID: 2906019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers.
    Silke B; Thompson A; Leitch A; Riddell JG
    Br J Clin Pharmacol; 1995 Jul; 40(1):37-42. PubMed ID: 8527266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.
    Silke B; Verma SP; Guy S
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):681-7. PubMed ID: 1679661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of celiprolol on systemic and forearm circulation in hypertensive patients: a double-blind cross-over study versus metoprolol.
    Trimarco B; Lembo G; De Luca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Clin Pharmacol; 1987 Aug; 27(8):593-600. PubMed ID: 2888795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Clin Pharmacol Ther; 1986 Jan; 39(1):5-14. PubMed ID: 2935349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cardiovascular and pulmonary effects of oral celiprolol, propranolol and placebo in normal volunteers.
    Busst CM; Bush A
    Br J Clin Pharmacol; 1989 Apr; 27(4):405-10. PubMed ID: 2566321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of celiprolol, a new beta 1-alpha 2 blocker, on the cardiovascular response to exercise.
    Caruso FS; Berger BM; Darragh A; Weng T; Vukovich R
    J Clin Pharmacol; 1986 Jan; 26(1):32-8. PubMed ID: 2869057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting actions of celiprolol and metoprolol on cardiac performance in normal volunteers.
    Silke B; Thompson A; Riddell JG
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):57-61. PubMed ID: 9140679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
    J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of beta-1-adrenergic blocking agents with ISA or without ISA on peripheral blood flow.
    Karnik R; Valentin A; Slany J
    Angiology; 1987 Apr; 38(4):296-303. PubMed ID: 2883920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central and peripheral hemodynamics of celiprolol.
    Mancia G
    Am Heart J; 1988 Nov; 116(5 Pt 2):1405-11. PubMed ID: 2903651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.